In vivo CAR T cell engineering
Delivering CAR T cell engineering directly inside patients could eventually expand access to this powerful cancer treatment by avoiding expensive, complex manufacturing outside the body.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Efficacy of preoperative GLP-1 receptor agonists on the perioperative…
GLP-1 drugs before weight-loss surgery show safety but don't meaningfully improve outcomes, helping doctors make clearer decisions about prescribing in this specific setting.
Near-term implementable findingEnhancing Diagnostic Precision in Malignant Hematological Disorders…
Simple blood test patterns before bone marrow procedures can now predict which patients need extra care to get reliable diagnostic results for blood cancers.
Near-term implementable findingInfluence of computed tomography reconstruction algorithms on…
New deep-learning CT imaging reduces reader disagreement on heart disease risk scores, making cardiovascular risk assessment more consistent and reliable across patients.
Underserved or high-risk populationsPrimary brainstem lymphoma
Standard chemotherapy remains effective for a rare brain lymphoma subtype previously unclear in treatment response, with age guiding which patients need intensified approaches.